logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
O

Olatunji B. Alese

Emory University
H指数:31
被引数:4,094

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling

一项XL888（HSP90抑制剂）与pembrolizumab联合治疗转移性胰腺癌的Phase Ib/II临床试验，并进行转化性免疫谱分析

Cancer Letters
IF10.1
2025-12-230
OAAI
Natalie K. Horvat; Maria Diab; Maggie J. Phillips; Ashley Veal-McCook; Erin E. Grundy; Olatunji B. Alese; Emily Greene; Olumide Gbolahan; Kathleen Coleman; Deon Doxie; Cameron J. Herting; Jacklyn Hammons; Zaid Mahdi; Jeffrey M. Switchenko; Chrystal M. Paulos; Bassel F. El-Rayes; Gregory B. Lesinski
Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 study

rucaparib和脂质体伊立替康/5-氟尿嘧啶在转移性消化道肿瘤中的优化给药方案：一项1期研究

Cancer
IF5.1
2025-11-220
PRE
Cody Eslinger MD, MS; Daniel Walden MD; Alexandra Krivonos BS; Numrah Fadra PhD; Tyler Zemla MS; Wen Wee Ma MBBS; Bassel El-Rayes MD; Olatunji Alese MD; Thorvardur Halfdanarson MD; Timothy Hobday MD; Sarah Bruggeman BS; Brandy Jaszewski BS; Fang-Shu Ou PhD; Mohamad Bassam Sonbol MD; Daniel Ahn DO; Mitesh J. Borad MD; Christina Wu MB, BCh, MD; Robert McWilliams MD; Tanios Bekaii-Saab MD
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma

I期ADP-A2AFP TCR T细胞疗法在晚期肝细胞癌或胃肝样腺癌患者中的临床试验

Journal of Hepatology
IF33
2025-08-120
PREAI
Tim Meyer; Richard S. Finn; Mitesh Borad; Amit Mahipal; Julien Edeline; Roch Houot; Petr F. Hausner; Antoine Hollebecque; Lipika Goyal; Matthew Frigault; Thomas R. Jeffry Evans; Kit Man Wong; Benjamin R. Tan; Emmanuel Mitry; Debashis Sarker; Lynn Feun; Bassel El-Rayes; Fiona Thistlethwaite; Ahmed Kaseb; Olatunji Alese
Utilizing Patient Input in Rectal Cancer Trial Design

利用患者反馈进行直肠癌试验设计

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
2025-03-190
PRE
Alvarez, Janet; Zambare, Wini; George, Manju; Garcia, Reese; Gallagher, Phuong; Kitchens, Caleah; Bercz, Aron; Kim, Min Jung; Romesser, Paul B.; Cercek, Andrea; Garcia-Aguilar, Julio; Sanoff, Hanna; George, Thomas J.; Hong, Theodore S.; Yothers, Greg; Philip, Philip A.; Al Baghdadi, Tareq; Alese, Olatunji B.; Shergill, Ardaman; O'Reilly, Eileen M.; Meyerhardt, Jeffrey A.; Horvat, Natally; Dasari, Arvind; Hall, William A.; Shi, Qian; Schrag, Deborah; Smith, J. Joshua
XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial

XL888和pembrolizumab在Ib/II期临床试验中调节结直肠癌的免疫景观。

OncoImmunology
IF6.3
2025-03-130
OA
Maggie J. Phillips; Olatunji B. Alese; Natalie K. Horvat; Emily Greene; Olumide B. Gbolahan; Kathleen Coleman; Deon B. Doxie; Vaunita Parihar; Zaid K. Mahdi; Ashley McCook-Veal; Jeffrey M. Switchenko; Maria Diab; Cameron J. Herting; Chrystal M. Paulos; Bassel F. El-Rayes; Gregory B. Lesinski
Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine

使用帕立骨化醇和羟氯喹增强胰腺导管腺癌化疗疗效的机制

CELL REPORTS MEDICINE
IF10.6
2025-01-012
OAAI
Nagaraju, Ganji Purnachandra; Saddala, Madhu Sudhana; Foote, Jeremy B.; Khaliq, Ateeq M.; Masood, Ashiq; Golivi, Yuvasri; Bandi, Dhana Sekhar Reddy; Sarvesh, Sujith; Reddy, Sudhir Putty; Switchenko, Jeffrey; Carstens, Julienne L.; Akce, Mehmet; Herting, Cameron; Alese, Olatunji B.; Yoon, Karina J.; Manne, Upender; Bhasin, Manoj K.; Lesinski, Gregory B.; Sukhatme, Vikas P.; El-Rayes, Bassel F.
Phase I trial of the delta-like ligand-3 (DLL3)/CD3 IgG-Like T cell engager BI 764532 in patients (pts) with DLL3-positive tumors: Updated data

delta-like ligand-3 (DLL3)/CD3 IgG样T细胞结合剂BI 764532在DLL3阳性肿瘤患者(pts)中的I期试验：更新数据

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Wermke, M.; Gambardella, V.; Kuboki, Y.; Felip, E.; Sanmamed, M. F.; Alese, O.; Sayehli, C. M.; Arriola Aperribay, E.; Wolf, J.; Villaruz, L.; Studeny, M.; Bouzaggou, M.; Fang, X.; Morgensztern, D.
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer

Alliance A022104/NRG-GI010: Janus直肠癌试验: 一项随机II/III期试验，测试三联化疗与双联化疗在局部晚期直肠癌患者中的临床完全反应和无病生存期的疗效

BMC CANCER
IF3.4
2024-07-268
OAAI
Alvarez, Janet A.; Shi, Qian; Dasari, Arvind; Garcia-Aguilar, Julio; Sanoff, Hanna; George, Thomas J.; Hong, Theodore; Yothers, Greg; Philip, Philip; Nelson, Garth; Al Baghdadi, Tareq; Alese, Olatunji B.; Zambare, Wini; Omer, Dana; Verheij, Floris S.; Bercz, Aron; Kim, Min Jung; Buckley, James; Williams, Hannah; George, Manju; Garcia, Reese; Gallagher, Phuong; O'Reilly, Eileen M.; Meyerhardt, Jeffrey A.; Crawley, Jamie; Shergill, Ardaman; Horvat, Natally; Romesser, Paul B.; Hall, William; Smith, J. Joshua
Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells
NUCLEIC ACIDS RESEARCH
IF13.1
2024-05-231
OAAI
Cinar, Munevver; Martinez-Medina, Lourdes; Puvvula, Pavan K.; Arakelyan, Arsen; Vardarajan, Badri N.; Anthony, Neil; Nagaraju, Ganji P.; Park, Dongkyoo; Feng, Lei; Sheff, Faith; Mosunjac, Marina; Saxe, Debra; Flygare, Steven; Alese, Olatunji B.; Kaufman, Jonathan L.; Lonial, Sagar; Sarmiento, Juan M.; Lossos, Izidore S.; Vertino, Paula M.; Lopez, Jose A.; El-Rayes, Bassel; Bernal-Mizrachi, Leon
Phase Ib study of siltuximab and spartalizumab in advanced pancreatic cancer

siltuximab和spartalizumab治疗晚期胰腺癌的Ib期研究

CANCER RESEARCH
IF16.6
2024-04-050
PRE
Alese, Olatunji B.; Gbolahan, Olumide; Coleman, Kathleen M.; Cao, Yichun; Kane, Sujata; Craven, Sarah; Greene, Emily; Horvat, Natalie; McDonald, Andrew; Shaib, Walid L.; Wu, Christina S.; Akce, Mehmet; Diab, Maria; Switchenko, Jeffrey M.; Lesinski, Gregory B.; El-Rayes, Bassel F.
Palbociclib (P) in patients (pts) with solid tumors with CCND1 amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

患有CCND1扩增 (amp) 或突变 (mut) 的实体瘤患者 (pts) 的Palbociclib (P): 靶向药物和分析利用注册中心 (TAPUR) 研究的结果

CANCER RESEARCH
IF16.6
2024-04-050
PRE
Thota, Ramya; Rothe, Michael; Mangat, Pam K.; Garrett-Mayer, Elizabeth; Al Baghdadi, Tareq; Pisick, Evan; Alese, Olatunji B.; Duvivier, Herbert L.; Alva, Ajjai S.; Ganti, Apar Kishor; Induru, Raghava R.; Tsimberidou, Apostolia M.; Akce, Mehmet; Hafez, Navid; Hobbs, Evthokia; Riddle, Andrew; von Mehren, Margaret; Grantham, Gina N.; Gregory, Abigail; Hinshaw, Dominique C.; Halabi, Susan; Schilsky, Richard L.

研究方向

暂未获取到该数据
B
Bassel F. El‐Rayes
H 指数:63论文数:700被引数:1.5万
W
Walid L. Shaib
H 指数:35论文数:191被引数:5,539
C
Christina Wu
H 指数:37论文数:343被引数:6,484
M
Mehmet Akce
H 指数:21论文数:199被引数:3,605
T
Taofeek K. Owonikoko
H 指数:88论文数:735被引数:6.4万
G
Gregory B. Lesinski
H 指数:52论文数:464被引数:8,277
S
Suresh S. Ramalingam
H 指数:124论文数:1,237被引数:10.4万
M
Mehmet Asım Bilen
H 指数:49论文数:665被引数:1.1万
C
Conor Steuer
H 指数:35论文数:291被引数:6,466
J
Juan M. Sarmiento
H 指数:50论文数:317被引数:8,500